Westlake Chemical Partners (WLKP)

$21.98

+0.04

(+0.18%)▲

Market is closed - opens 7 PM, 26 Apr 2024

Insights on Westlake Chemical Partners

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 321.66M → 297.27M (in $), with an average decrease of 7.6% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, 11.88M → 14.29M (in $), with an average increase of 8.8% per quarter

  • Vs CE

    In the last 1 year, Celanese Corporation has given 53.2% return, outperforming this stock by 55.1%

  • Vs CE

    In the last 3 years, Westlake Chemical Partners has experienced a drawdown of -18.8%, however Celanese Corporation resisted the overall trend and outperformed by 16.3%

Performance

  • $21.76
    $22.07
    $21.98
    downward going graph

    1.0%

    Downside

    Day's Volatility :1.38%

    Upside

    0.39%

    downward going graph
  • $19.30
    $23.62
    $21.98
    downward going graph

    12.19%

    Downside

    52 Weeks Volatility :18.29%

    Upside

    6.94%

    downward going graph

Returns

PeriodWestlake Chemical PartnersSector (Materials)Index (Russel 2000)
3 Months
-5.46%
7.8%
0.0%
6 Months
3.92%
18.7%
0.0%
1 Year
-1.92%
13.3%
2.2%
3 Years
-18.8%
6.7%
-23.0%

Highlights

Market Capitalization
772.9M
Book Value
$14.83
Dividend Share
1.886
Dividend Yield
8.59%
Earnings Per Share (EPS)
1.54
PE Ratio
14.25
PEG Ratio
0.23
Wall Street Target Price
44.2
Profit Margin
4.56%
Operating Margin TTM
31.22%
Return On Assets TTM
16.63%
Return On Equity TTM
38.03%
Revenue TTM
1.2B
Revenue Per Share TTM
33.81
Quarterly Revenue Growth YOY
-19.0%
Gross Profit TTM
377.4M
EBITDA
467.9M
Diluted Eps TTM
1.54
Quarterly Earnings Growth YOY
-0.15
EPS Estimate Current Year
1.67
EPS Estimate Next Year
2.18
EPS Estimate Current Quarter
0.44
EPS Estimate Next Quarter
0.47

Analyst Recommendation

Buy
    63%Buy
    27%Hold
    9%Sell
Based on 11 Wall street analysts offering stock ratings for Westlake Chemical Partners(by analysts ranked 0 to 5 stars)
Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
8
Hold
3
3
3
Sell
1
1
1

Analyst Forecast

What analysts predicted

Upside of 101.09%

Current $21.98
Target $44.20

Company Financials

FY18Y/Y Change
Revenue
1.3B
↑ 9.6%
Net Income
49.3M
↑ 1.39%
Net Profit Margin
3.84%
↓ 0.31%
FY19Y/Y Change
Revenue
1.1B
↓ 15.07%
Net Income
332.9M
↑ 574.6%
Net Profit Margin
30.49%
↑ 26.65%
FY20Y/Y Change
Revenue
966.7M
↓ 11.47%
Net Income
341.1M
↑ 2.47%
Net Profit Margin
35.29%
↑ 4.8%
FY21Y/Y Change
Revenue
1.2B
↑ 25.67%
Net Income
401.4M
↑ 17.67%
Net Profit Margin
33.04%
↓ 2.25%
FY22Y/Y Change
Revenue
1.6B
↑ 31.14%
Net Income
334.8M
↓ 16.58%
Net Profit Margin
21.02%
↓ 12.02%
FY23Y/Y Change
Revenue
1.2B
↓ 25.26%
Net Income
54.3M
↓ 83.79%
Net Profit Margin
4.56%
↓ 16.46%
Q3 FY22Q/Q Change
Revenue
415.1M
↓ 7.5%
Net Income
78.3M
↓ 7.26%
Net Profit Margin
18.86%
↑ 0.04%
Q4 FY22Q/Q Change
Revenue
366.8M
↓ 11.63%
Net Income
91.3M
↑ 16.54%
Net Profit Margin
24.88%
↑ 6.02%
Q1 FY23Q/Q Change
Revenue
307.7M
↓ 16.13%
Net Income
91.5M
↑ 0.21%
Net Profit Margin
29.72%
↑ 4.84%
Q2 FY23Q/Q Change
Revenue
264.2M
↓ 14.14%
Net Income
11.9M
↓ 87.0%
Net Profit Margin
4.5%
↓ 25.22%
Q3 FY23Q/Q Change
Revenue
321.7M
↑ 21.76%
Net Income
13.2M
↑ 11.11%
Net Profit Margin
4.11%
↓ 0.39%
Q4 FY23Q/Q Change
Revenue
297.3M
↓ 7.58%
Net Income
14.3M
↑ 8.28%
Net Profit Margin
4.81%
↑ 0.7%
FY18Y/Y Change
Total Assets
1.5B
↓ 3.51%
Total Liabilities
528.0M
↑ 2.23%
FY19Y/Y Change
Total Assets
1.4B
↓ 4.7%
Total Liabilities
441.3M
↓ 16.42%
FY20Y/Y Change
Total Assets
1.4B
↓ 2.65%
Total Liabilities
441.4M
↑ 0.01%
FY21Y/Y Change
Total Assets
1.5B
↑ 9.16%
Total Liabilities
508.0M
↑ 15.1%
FY22Y/Y Change
Total Assets
1.4B
↓ 7.34%
Total Liabilities
468.3M
↓ 7.82%
FY23Y/Y Change
Total Assets
1.3B
↓ 4.02%
Total Liabilities
460.6M
↓ 1.64%
Q3 FY22Q/Q Change
Total Assets
1.4B
↓ 2.12%
Total Liabilities
479.0M
↓ 2.88%
Q4 FY22Q/Q Change
Total Assets
1.4B
↓ 4.14%
Total Liabilities
468.3M
↓ 2.24%
Q1 FY23Q/Q Change
Total Assets
1.3B
↓ 2.14%
Total Liabilities
452.8M
↓ 3.3%
Q2 FY23Q/Q Change
Total Assets
1.3B
↓ 0.53%
Total Liabilities
467.6M
↑ 3.27%
Q3 FY23Q/Q Change
Total Assets
1.3B
↑ 0.44%
Total Liabilities
480.2M
↑ 2.7%
Q4 FY23Q/Q Change
Total Assets
1.3B
↓ 1.84%
Total Liabilities
460.6M
↓ 4.09%
FY18Y/Y Change
Operating Cash Flow
436.2M
↓ 18.83%
Investing Cash Flow
-51.8M
↓ 74.51%
Financing Cash Flow
-391.6M
↓ 1.12%
FY19Y/Y Change
Operating Cash Flow
450.8M
↑ 3.36%
Investing Cash Flow
-57.7M
↑ 11.38%
Financing Cash Flow
-392.9M
↑ 0.34%
FY20Y/Y Change
Operating Cash Flow
373.4M
↓ 17.17%
Investing Cash Flow
2.0M
↓ 103.52%
Financing Cash Flow
-378.2M
↓ 3.75%
FY21Y/Y Change
Operating Cash Flow
408.4M
↑ 9.38%
Investing Cash Flow
-64.3M
↓ 3264.42%
Financing Cash Flow
-344.2M
↓ 8.98%
FY22Y/Y Change
Operating Cash Flow
463.7M
↑ 13.54%
Investing Cash Flow
-12.0M
↓ 81.33%
Financing Cash Flow
-404.0M
↑ 17.36%
Q3 FY22Q/Q Change
Operating Cash Flow
115.5M
↓ 4.44%
Investing Cash Flow
-19.1M
↓ 36.24%
Financing Cash Flow
-95.3M
↑ 3.86%
Q4 FY22Q/Q Change
Operating Cash Flow
122.6M
↑ 6.13%
Investing Cash Flow
62.5M
↓ 426.58%
Financing Cash Flow
-139.7M
↑ 46.65%
Q1 FY23Q/Q Change
Operating Cash Flow
144.9M
↑ 18.18%
Investing Cash Flow
228.0K
↓ 99.63%
Financing Cash Flow
-105.3M
↓ 24.65%
Q2 FY23Q/Q Change
Operating Cash Flow
98.5M
↓ 31.97%
Investing Cash Flow
-46.5M
↓ 20500.44%
Financing Cash Flow
-97.2M
↓ 7.69%
Q3 FY23Q/Q Change
Operating Cash Flow
100.9M
↑ 2.42%
Investing Cash Flow
-6.8M
↓ 85.36%
Financing Cash Flow
-87.7M
↓ 9.78%

Technicals Summary

Sell

Neutral

Buy

Westlake Chemical Partners is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Westlake Chemical Partners
Westlake Chemical Partners
-0.81%
3.92%
-1.92%
-18.8%
-2.53%
Braskem S.a.
Braskem S.a.
-16.07%
22.82%
16.58%
-55.94%
-63.22%
Dow Inc.
Dow Inc.
-1.1%
17.53%
7.34%
-9.26%
2.15%
Celanese Corporation
Celanese Corporation
-7.53%
31.98%
53.19%
-2.45%
41.76%
Huntsman Corporation
Huntsman Corporation
-6.88%
2.2%
-7.86%
-18.13%
1.85%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Westlake Chemical Partners
Westlake Chemical Partners
14.25
14.25
0.23
1.67
0.38
0.17
0.09
14.83
Braskem S.a.
Braskem S.a.
26.15
NA
-1.31
-1.48
-1.04
0.0
NA
5.01
Dow Inc.
Dow Inc.
69.49
69.49
0.78
3.02
0.03
0.03
0.05
26.5
Celanese Corporation
Celanese Corporation
8.64
8.64
4.42
11.38
0.29
0.03
0.02
65.11
Huntsman Corporation
Huntsman Corporation
46.54
NA
1.79
0.5
0.01
0.01
0.04
18.95
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Westlake Chemical Partners
Westlake Chemical Partners
Buy
$772.9M
-2.53%
14.25
4.56%
Braskem S.a.
Braskem S.a.
Buy
$3.5B
-63.22%
26.15
-6.49%
Dow Inc.
Dow Inc.
Hold
$40.3B
2.15%
69.49
1.32%
Celanese Corporation
Celanese Corporation
Buy
$17.4B
41.76%
8.64
17.92%
Huntsman Corporation
Huntsman Corporation
Hold
$4.2B
1.85%
46.54
1.65%

Institutional Holdings

  • Amvescap Plc.

    14.94%

  • Energy Income Partners, LLC

    5.91%

  • Mirae Asset Global Investments (Korea) Co Ltd

    1.64%

  • UBS Group AG

    1.53%

  • ClearBridge Advisors, LLC

    1.20%

  • Goldman Sachs Group Inc

    0.78%

Corporate Announcements

  • Westlake Chemical Partners Dividends March,2024

    In the quarter ending March,2024. Westlake Chemical Partners has declared dividend of $0.47

    Read More

Company Information

Organization
Westlake Chemical Partners
Employees
0
CEO
Mr. Albert Yuan Chao
Industry
Process Industries

Discover More

FAQs